These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Author: Haddock G, Gray HW, McKillop JH, Bessent RG, Kirk D.
    Journal: Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008.
    Abstract:
    Bone marrow scintigraphy was performed in 23 patients with histologically proven carcinoma of the prostate, using a new radiopharmaceutical, Technetium-99m nanocolloid. The results suggest that although bone marrow scintigraphy is less sensitive than conventional bone scintigraphy in the detection of skeletal metastases from prostatic carcinoma, the technique may have a place in the management of patients with advanced metastatic disease, especially those who are anaemic, by identifying those patients at risk from myelosuppressive therapy.
    [Abstract] [Full Text] [Related] [New Search]